Abstract 81P
Background
Single-cell technologies have revealed novel insights about the complexity of the tumor immune microenvironment. Most clinical strategies rely on histopathological stratification of tumor subtypes, yet the spatial context of cellular interactions within these stratified subgroups remains poorly understood. We previously applied imaging mass cytometry, a novel technology, to describe the tumor and immunological landscape of lung adenocarcinoma (LUAD) patient tumors across five histological subtypes of lung adenocarcinoma. We resolved over 1 million cells, enabling an understanding of the cellular spatial relationships associated with distinct clinical correlates, such as survival. Here, we compare the immune landscape of LUAD with lung squamous cell carcinoma (LUSC), a different subtype of lung cancer.
Methods
Imaging mass cytometry (IMC) is a novel technology which allows for the use of up to 50 antibodies labelled with metal isotopes to characterize the tumour and the tumour immune microenvironment. Our research group has optimized a panel of IMC markers delineating immune, tumour and structural cell types. Using IMC we have assessed the frequency of 16 different cell types, the interactions across these cells and their organization into cellular communities. We have compared these outputs across LUAD and LUSC patients.
Results
We show that LUAD and LUSC exhibit distinct immune profiles. Lung squamous cell carcinoma is characterized by a higher prevalence of neutrophils and a lower prevalence of macrophages compared to LUAD. In addition, our spatial analysis of immune lineages demonstrates contrasting cellular interactions across LUAD and LUSC as well as unique arrangements of immune cells into cellular neighborhoods. This highlights the spatial heterogeneity that exists across lung cancer subtypes beyond the prevalence of immune cell types alone.
Conclusions
Our results describe the importance of spatial interactions by demonstrating how distinct spatial profiles can exist across subtypes of lung cancer. Overall, we find unique immune profiles across LUAD and LUSC as it relates to immune frequencies, pairwise cellular interactions and communities of cells.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Rosalind and Morris Goodman Chair in Lung Cancer Research.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
10P - An adapted CGP-based model to interpret POLE mutations in endometrial cancer
Presenter: Rita Trozzi
Session: Cocktail & Poster Display session
Resources:
Abstract
11P - Reconstructing tumour evolution of single cells using both somatic mutations and copy-number alterations
Presenter: Rija Zaidi
Session: Cocktail & Poster Display session
Resources:
Abstract
12P - Swiss-PO: Molecular modelling for precision oncology
Presenter: Fanny Krebs
Session: Cocktail & Poster Display session
Resources:
Abstract
13P - A novel algorithm for predicting variant detectability in oncogenomic analysis
Presenter: Alper Akkuş
Session: Cocktail & Poster Display session
Resources:
Abstract
14P - expHRD: An algorithm for the transcriptome-based estimation of homologous recombination deficiency score
Presenter: Jin-Ku Lee
Session: Cocktail & Poster Display session
Resources:
Abstract
15P - ClinBioNGS: An integrated clinical bioinformatics pipeline for the analysis of somatic NGS cancer panels
Presenter: Xavier Sole
Session: Cocktail & Poster Display session
Resources:
Abstract
16P - Investigation of c-MYC role in DNA-PK-mediated activation of STING pathway in SCLC
Presenter: Caterina de Rosa
Session: Cocktail & Poster Display session
Resources:
Abstract
17P - NRF2 activation promotes HER2-targeted tolerance and resistance in oesophageal adenocarcinoma through metabolic reprogramming to glutathione
Presenter: Wei Zhang
Session: Cocktail & Poster Display session
Resources:
Abstract
18P - AURKB inhibition radiosensitises NSCLC by altering mitotic fate
Presenter: Kathryn Egerton
Session: Cocktail & Poster Display session
Resources:
Abstract
19P - Stratified control study on neuroendocrine differentiation and potential clinical markers in patients with limited-stage small-cell lung cancer
Presenter: Li Liu
Session: Cocktail & Poster Display session
Resources:
Abstract